KNTK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kinetik Holdings Inc (KNTK) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and bullish technical indicators outweigh the insider selling and hedge fund exit. The asset aligns with the user's investment strategy and risk tolerance.
The technical indicators for KNTK are bullish. The MACD histogram is positive at 0.0293, indicating upward momentum. The RSI is neutral at 55.945, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 45.483, with resistance at 47.697 and support at 43.27.
Hedge funds are heavily buying, with a 3936.59% increase in buying activity last quarter.
Analysts have raised price targets recently, with Goldman Sachs and Citi projecting higher valuations ($49 and $51, respectively).
Strong financial performance in Q4 2025, with revenue up 11.59% YoY and net income up 44149.37% YoY.
Bullish technical indicators suggest upward momentum.
Insiders are selling, with a 61466.55% increase in selling activity last month.
Brave Warrior Advisors sold its entire holding of KNTK, marking a complete exit from the midstream energy sector.
Some analysts, like Jefferies and Wolfe Research, have downgraded the stock due to valuation concerns.
Kinetik Holdings reported strong financials in Q4 2025. Revenue increased by 11.59% YoY to $430.42 million, net income surged by 44149.37% YoY to $139.83 million, and EPS rose by 21700% YoY to 2.18. The gross margin also improved to 35.02%, up 16.81% YoY. The company expects adjusted EBITDA for 2026 to range between $950 million and $1.05 billion, indicating continued growth.
Recent analyst ratings are mostly positive. Goldman Sachs and Citi raised their price targets to $49 and $51, respectively, citing strong earnings and a positive growth outlook. However, some analysts, like Jefferies and Wolfe Research, have expressed concerns about valuation and downgraded the stock. The consensus is mixed but leans towards a positive long-term outlook.
